BCL2 and B-cell chronic lymphocytic leukemia: In the latter case, GSK-3 inhibition by AR-A014418 enhanced apoptosis in CLL B-cells via downregulation of the expression of X-linked inhibitor of apoptosis protein (XIAP) and Bcl-2.